Loblaw Companies Limited · TSX:L
Loblaw Companies — Q3 2025 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Nov 12, 2025
Slide 1: Supplementary Slides Q3 2025
SUPPLEMENTARY SLIDES Q3 2025 For the periods ended October 4, 2025 and October 5, 2024 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q3 2025 (millions of Canadian dollars unless otherwise noted) Q3 2025 Q3 2024 % Change (1) Consolidated Revenue $19,395 $18,538 ↑ +4.6% Adjusted EBITDA $2,217 $2,069 ↑ +7.2% Adjusted EBITDA Margin 11.4% 11.2% ↑ 20bps Adjusted Net Earnings Avaliable to Common Shar
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q3 2025 (millions of Canadian dollars unless otherwise noted) Q3 2025 Q3 2024 % Change (1) Total Retail Revenue $19,082 $18,259 ↑ 4.5% Retail Revenue - Food $13,588 $12,966 ↑ 4.8% Retail Revenue - Drug $5,494 $5,293 ↑ 3.8% Pharmacy and Healthcare Services $2,95
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q3 2025 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +2.0% Basket Size(2) ↑ Traffic(2) ↑ Loblaw STM Square Footage Growth ↑ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +4.0